CLINiLABS Opens Phase I Unit
Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, recently announced it has opened a second Phase I unit in
Since 2001, Clinilabs has successfully completed clinical trials involving healthy, adult human volunteers and specialty patient populations. The staff has accrued experience in over 800 clinical studies, offering clients the service capacity of a big CRO – delivered by an organization that is right-sized and priced for early phase projects. The opening of the New Jersey Specialty Pharma Phase I Unit expands services currently offered at the company’s 50-bed, state-of-the-art, Phase I unit in
“I am pleased to announce the opening of our new unit in
Clinilabs is a contract research organization that provides early phase and specialty clinical drug development services to industry. The company offer teams, processes, and technology solutions that are designed to serve single center and multicenter early phase studies – services that can be scaled as needed to meet the requirements of any clinical development program. For more information, visit www.clinilabs.com.
Total Page Views: 1026
